We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ResVerlogiX

News List

Resverlogix holds discussions with Morocco to start Covid-19 drug trial Pharmaceutical-Technology
November 03, 2021
Resverlogix is holding talks with the Ministry of Health of the Kingdom of Morocco to conduct Phase II clinical trials of its drug, apabetalone (RVX-208), for Covid-19.
Resverlogix Receives Approval Pathway from the FDA as to the Inclusion of USA Patients in the Phase en-cphi.cn
July 26, 2017
"BETonMACE Phase 3 Trial with apabetalone to expand to include the United States"
Resverlogix Receives Approval From The FDA Cardiovascular and Renal Division To Proceed With A Reque en-cphi.cn
May 16, 2017
Apabetalone expands to a second major clinical indication in kidney dialysis patients